Alex Page1, Mehmet K Aktas2, Tolga Soyata1, Wojciech Zareba3, Jean-Philippe Couderc4. 1. Electrical and Computer Engineering Department, University of Rochester, Rochester, New York. 2. Cardiology Department, University of Rochester Medical Center, Rochester, New York. 3. Heart Research Follow Up Program, Rochester, New York. 4. Electrical and Computer Engineering Department, University of Rochester, Rochester, New York; Heart Research Follow Up Program, Rochester, New York. Electronic address: Jean-Philippe.Couderc@heart.rochester.edu.
Abstract
BACKGROUND: The QT interval is a risk marker for cardiac events such as torsades de pointes. However, QT measurements obtained from a 12-lead ECG during clinic hours may not capture the full extent of a patient's daily QT range. OBJECTIVE: The purpose of this study was to evaluate the utility of 24-hour Holter ECG recording in patients with long QT syndrome (LQTS) to identify dynamic changes in the heart rate-corrected QT interval and to investigate methods of visualizing the resulting datasets. METHODS: Beat-to-beat QTc (Bazett) intervals were automatically measured across 24-hour Holter recordings from 202 LQTS type 1, 89 type 2, and 14 type 3 genotyped patients and a reference group of 200 healthy individuals. We measured the percentage of beats with QTc greater than the gender-specific threshold (QTc ≥470 ms in women and QTc ≥450 ms in men). The percentage of beats with QTc prolongation was determined across the 24-hour recordings. RESULTS: Based on the median percentage of heartbeats per patient with QTc prolongation, LQTS type 1 patients showed more frequent QTc prolongation during the day (~3 PM) than they did at night (~3 AM): 97% vs 48%, P ~10(-4) for men, and 68% vs 30%, P ~10(-5) for women. LQTS type 2 patients showed less frequent QTc prolongation during the day compared to nighttime: 87% vs 100%, P ~10(-4) for men, and 62% vs 100%, P ~10(-3) for women. CONCLUSION: In patients with genotype-positive LQTS, significant differences exist in the degree of daytime and nocturnal QTc prolongation. Holter monitoring using the "QT clock" concept may provide an easy, fast, and accurate method for assessing the true personalized burden of QTc prolongation.
BACKGROUND: The QT interval is a risk marker for cardiac events such as torsades de pointes. However, QT measurements obtained from a 12-lead ECG during clinic hours may not capture the full extent of a patient's daily QT range. OBJECTIVE: The purpose of this study was to evaluate the utility of 24-hour Holter ECG recording in patients with long QT syndrome (LQTS) to identify dynamic changes in the heart rate-corrected QT interval and to investigate methods of visualizing the resulting datasets. METHODS: Beat-to-beat QTc (Bazett) intervals were automatically measured across 24-hour Holter recordings from 202 LQTS type 1, 89 type 2, and 14 type 3 genotyped patients and a reference group of 200 healthy individuals. We measured the percentage of beats with QTc greater than the gender-specific threshold (QTc ≥470 ms in women and QTc ≥450 ms in men). The percentage of beats with QTc prolongation was determined across the 24-hour recordings. RESULTS: Based on the median percentage of heartbeats per patient with QTc prolongation, LQTS type 1 patients showed more frequent QTc prolongation during the day (~3 PM) than they did at night (~3 AM): 97% vs 48%, P ~10(-4) for men, and 68% vs 30%, P ~10(-5) for women. LQTS type 2 patients showed less frequent QTc prolongation during the day compared to nighttime: 87% vs 100%, P ~10(-4) for men, and 62% vs 100%, P ~10(-3) for women. CONCLUSION: In patients with genotype-positive LQTS, significant differences exist in the degree of daytime and nocturnal QTc prolongation. Holter monitoring using the "QT clock" concept may provide an easy, fast, and accurate method for assessing the true personalized burden of QTc prolongation.
Authors: Dimitry Migdalovich; Arthur J Moss; Coeli M Lopes; Jason Costa; Gregory Ouellet; Alon Barsheshet; Scott McNitt; Slava Polonsky; Jennifer L Robinson; Wojciech Zareba; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Pyotr G Platonov; Wataru Shimizu; Jeffrey A Towbin; G Michael Vincent; Arthur A M Wilde; Ilan Goldenberg Journal: Heart Rhythm Date: 2011-03-25 Impact factor: 6.343
Authors: P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise Journal: Circulation Date: 2001-01-02 Impact factor: 29.690
Authors: Chi-un Choe; Eric Schulze-Bahr; Axel Neu; Jun Xu; Zheng I Zhu; Kathrin Sauter; Robert Bähring; Silvia Priori; Pascale Guicheney; Gerold Mönnig; Carlo Neapolitano; Jan Heidemann; Colleen E Clancy; Olaf Pongs; Dirk Isbrandt Journal: Hum Mol Genet Date: 2006-08-21 Impact factor: 6.150
Authors: Wataru Shimizu; Arthur J Moss; Arthur A M Wilde; Jeffrey A Towbin; Michael J Ackerman; Craig T January; David J Tester; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Elizabeth S Kaufman; Nynke Hofman; Takashi Noda; Shiro Kamakura; Yoshihiro Miyamoto; Samit Shah; Vinit Amin; Ilan Goldenberg; Mark L Andrews; Scott McNitt Journal: J Am Coll Cardiol Date: 2009-11-24 Impact factor: 24.094
Authors: W Zareba; A J Moss; P J Schwartz; G M Vincent; J L Robinson; S G Priori; J Benhorin; E H Locati; J A Towbin; M T Keating; M H Lehmann; W J Hall Journal: N Engl J Med Date: 1998-10-01 Impact factor: 91.245
Authors: T Noda; H Takaki; T Kurita; K Suyama; N Nagaya; A Taguchi; N Aihara; S Kamakura; K Sunagawa; K Nakamura; T Ohe; M Horie; C Napolitano; J A Towbin; S G Priori; W Shimizu Journal: Eur Heart J Date: 2002-06 Impact factor: 29.983
Authors: Wael Alqarawi; David H Birnie; Mehrdad Golian; Girish M Nair; Pablo B Nery; Andres Klein; Darryl R Davis; Mouhannad M Sadek; David Neilipovitz; Christopher B Johnson; Martin S Green; Calum Redpath Journal: CJC Open Date: 2020-07-22
Authors: Kathryn E Waddell-Smith; Alexandra A Chaptynova; Jian Li; Jackie R Crawford; Halina Hinds; Jonathan R Skinner Journal: J Cardiovasc Dev Dis Date: 2022-05-23
Authors: Hanna Lenhoff; Börje Darpö; Alex Page; Jean Philippe Couderc; Per Tornvall; Mats Frick Journal: Ann Noninvasive Electrocardiol Date: 2021-02-25 Impact factor: 1.468
Authors: Songwen Chen; Guannan Meng; Anisiia Doytchinova; Johnson Wong; Susan Straka; Julie Lacy; Xiaochun Li; Peng-Sheng Chen; Thomas H Everett Iv Journal: Front Physiol Date: 2021-12-22 Impact factor: 4.566
Authors: Adam P Hill; Matthew D Perry; Najah Abi-Gerges; Jean-Philippe Couderc; Bernard Fermini; Jules C Hancox; Bjorn C Knollmann; Gary R Mirams; Jon Skinner; Wojciech Zareba; Jamie I Vandenberg Journal: J Physiol Date: 2016-06-09 Impact factor: 5.182